NeoGenomics sales and marketing update

NeoGenomics launched its NeoLAB Solid Tumor Monitor test to quantify and track genomic abnormalities in tumors and its NeoLAB BTK Inhibitor Acquired Resistance test to predict resistance to Bruton’s t...